Detailed Information on Publication Record
1997
Serum IgD Levels in Children under Investigation and with Defined immunodeficiency
LITZMAN, Jiří, A.M. WARD, G. WILD, Vladimír ZNOJIL, G. MORGAN et. al.Basic information
Original name
Serum IgD Levels in Children under Investigation and with Defined immunodeficiency
Authors
LITZMAN, Jiří (203 Czech Republic, guarantor), A.M. WARD (826 United Kingdom of Great Britain and Northern Ireland), G. WILD (826 United Kingdom of Great Britain and Northern Ireland), Vladimír ZNOJIL (203 Czech Republic) and G. MORGAN (826 United Kingdom of Great Britain and Northern Ireland)
Edition
Int.Arch.Allerg.Immunol. Basel, Karger AG, 1997, 1018-2438
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.721
RIV identification code
RIV/00216224:14110/97:00030215
Organization unit
Faculty of Medicine
UT WoS
A1997XR99700008
Keywords in English
IgD; immunodeficiency; childhood
Tags
Změněno: 22/6/2009 16:29, prof. MUDr. Jiří Litzman, CSc.
V originále
BACKGROUND: The function and regulation of circulating IgD are unclear. Serum IgD levels were increased in a wide range of immunological diseases but these associations did not give a clue to the regulation of serum IgD production. METHODS: Serum IgD levels in 131 children with various non-HIV-related immunodeficiency diseases were investigated to examine their relationship with immunoglobulin or antibody production and activation of the immune system. Data from a group of 109 nonimmunodeficient children were also available for comparison. RESULTS: There was a bimodal distribution of serum IgD levels. In 87 patients IgD levels fell below the limit of detection of 5 IU/ml, while the remainder showed an approximately normal distribution skewed to the right after log transformation. The proportion of children with undetectable IgD levels (< 5 IU/ml) was significantly increased in immunodeficient children (87/131 vs. 28/109, p < 0.001). No difference in the occurrence of immunoglobulin or antibody deficiencies was demonstrated in immunodeficient children with detectable and nondetectable IgD levels. There was a positive correlation of serum IgD with age, serum IgA and IgE, white blood count and CD4+CD25+ lymphocytes but not with other immunoglobulin isotypes or immune activation markers. CONCLUSION: Determination of serum IgD levels did not seem to be of particular clinical benefit in the investigation of HIV-negative immunodeficient children and serum IgD levels were not associated with the general picture of immune activation. Observed distribution patterns and associations may have implications for the regulation of serum IgD production.
In Czech
Byla měřena hladina IgD u dětí s podezřením na primární imunodefcit.